Telegram
Global Blood Therapeutics GBT
$ 68.49
0.0%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиGlobal Blood Therapeutics Мультипликаторы 2011-2024 | GBT
Мультипликаторы по годам Global Blood Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-5.8 | -12.4 | -14.9 | -13.9 | -21.6 | -6.0 | -5.2 | - | - | - | - |
P/S |
9.1 | 24.8 | 1880.8 | - | - | - | - | - | - | - | - |
EPS |
-4.8 | -4.0 | -4.6 | -3.4 | -2.8 | -2.5 | -4.0 | -14.2 | -16.1 | - | - |
EV (Enterprise Value) |
1.82 млрд | 2.89 млрд | 3.88 млрд | 2.2 млрд | 2.36 млрд | 420 млн | 106 млн | 53 млн | 28.9 млн | - | - |
EBITDA per Share |
-4.48 | -3.8 | -4.79 | -3.48 | -2.78 | -2.47 | -3.55 | - | - | - | - |
EV/EBITDA |
-6.5 | -11.7 | -13.4 | -12.1 | -19.8 | -4.9 | -2.1 | - | - | - | - |
PEG |
-0.4 | -1.07 | 0.44 | 0.59 | 1.91 | -0.16 | 0.03 | - | - | - | - |
P/B |
9.0 | 7.4 | 6.9 | 4.2 | 7.9 | 2.7 | 1.7 | - | - | - | - |
P/CF |
-6.9 | -13.9 | -20.0 | -17.3 | -26.2 | -7.2 | -7.6 | - | - | - | - |
ROE % |
-154.32 | -59.49 | -46.10 | -30.41 | -36.71 | -44.26 | -32.93 | - | - | - | - |
ROA % |
-32.27 | -34.19 | -33.51 | -28.20 | -32.81 | -40.75 | -30.29 | - | - | - | - |
ROCE % |
-146.47 | -37.86 | -39.96 | -31.30 | -36.08 | -44.48 | -32.59 | - | - | - | - |
Current Ratio |
1.3 | 8.0 | 8.8 | 14.4 | 12.3 | 9.7 | 14.1 | 21.1 | - | - | - |
DSO |
43.4 | 51.6 | 456.6 | - | - | - | - | - | - | - | - |
DIO |
5416.9 | 7392.4 | 9710.5 | - | - | - | - | - | - | - | - |
DPO |
1880.9 | 3506.3 | 80763.9 | - | - | - | - | - | - | - | - |
Операционный цикл |
5460.3 | 7444.0 | 10167.1 | - | - | - | - | - | - | - | - |
Финансовый цикл |
3579.5 | 3937.8 | -70596.7 | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Global Blood Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | -1.26 | -1.26 | - | -1.13 | -1.12 | -1.21 | -1 | -0.97 | -0.86 | -1.2 | -1.59 | -1.07 | -1.01 | -0.87 | -0.93 | -0.83 | -0.78 | -0.87 | -0.95 | -0.66 | -0.55 | -0.6 | -0.74 | -0.58 | -0.58 | -0.56 | -0.53 | -0.9 | -4.84 | -4.22 | -3.27 | -3.53 | -3.68 | -3.81 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -1.11 | -1.11 | - | -1.07 | -1.01 | -1.13 | -0.96 | -0.83 | -0.75 | -1.17 | -1.64 | -1.04 | -1 | -0.9 | -0.94 | -0.83 | -0.8 | -0.88 | -0.91 | -0.65 | -0.55 | -0.6 | -0.75 | -0.56 | -0.57 | -0.56 | -0.53 | -0.82 | -3.7 | -3.53 | -2.72 | -2.77 | -3.01 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-200.12 | -153.47 | -176.49 | -128.85 | -65.70 | -80.55 | -71.91 | -62.57 | -59.49 | -61.22 | -57.98 | -55.19 | -46.10 | -38.10 | -34.47 | -31.61 | -30.41 | -34.76 | -36.20 | -36.64 | -36.71 | -38.37 | -40.68 | -42.67 | -44.26 | -40.73 | -39.95 | -36.57 | -32.93 | -11.09 | 9.99 | 26.56 | 31.83 | 21.06 | 10.47 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-28.31 | -30.52 | -42.20 | -44.04 | -34.53 | -43.06 | -39.65 | -35.64 | -34.19 | -37.71 | -37.55 | -37.45 | -33.51 | -29.42 | -28.28 | -27.62 | -28.20 | -31.80 | -32.83 | -32.99 | -32.81 | -34.68 | -37.05 | -39.09 | -40.75 | -37.56 | -36.84 | -33.72 | -30.36 | -29.63 | -29.35 | -33.00 | -28.16 | -18.63 | -9.26 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-182.63 | -140.48 | -162.31 | -119.25 | -62.40 | -76.67 | -68.85 | -60.43 | -58.43 | -61.31 | -59.18 | -57.18 | -48.61 | -40.55 | -36.62 | -33.53 | -31.90 | -35.96 | -37.17 | -37.42 | -37.40 | -39.00 | -41.19 | -43.09 | -44.62 | -40.96 | -40.10 | -36.65 | -32.95 | -11.10 | 9.94 | 26.44 | 31.71 | 20.94 | 10.40 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | 1.2 | 1.2 | 1.3 | 2.0 | 2.1 | 2.3 | 2.4 | 2.4 | 2.4 | 2.4 | 3.7 | 3.7 | 3.7 | 3.7 | 13.8 | 13.8 | 13.8 | 13.8 | 9.4 | 9.4 | 9.4 | 9.4 | 12.6 | 12.6 | 12.6 | 12.6 | 13.6 | 12.5 | 12.5 | 12.5 | 19.1 | 19.1 | 19.1 | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | 36.7 | 46.8 | - | 38.1 | 36.3 | 41.8 | 38.7 | 43.3 | 50.7 | 65.1 | 114.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | 4125.9 | 5196.8 | - | 5469.7 | 5505.4 | 6444.5 | - | 7154.7 | 9735.7 | 14025.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | 441.8 | 887.4 | - | 980.7 | 1193.9 | 2301.1 | - | 3393.5 | 4617.7 | 10037.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | 4162.6 | 5243.5 | - | 5507.7 | 5541.6 | 6486.3 | 38.7 | 7198.0 | 9786.4 | 14090.5 | 114.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | 3720.8 | 4356.1 | - | 4527.1 | 4347.7 | 4185.2 | 38.7 | 3804.5 | 5168.7 | 4053.4 | 114.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD